Abiopharma

🔍 Lawson Martin R (Director)

Company: MERCADOLIBRE INC (MELI)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 94 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,230.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: H | nature_of_ownership: By Fullerton Development Co | shares_owned_after: 1,769.00

Footnotes:

• F1: Represents 94 shares of stock, subject to forfeiture and transfer restrictions until the next annual meeting of the shareholders of MercadoLibre, Inc. following the transaction date.
• F2: Represents 559 shares of common stock subject to forfeiture and transfer restrictions ("Restricted Stock") and 3,671 shares of common stock. 465 shares of Retricted Stock will vest in two substantially equal installments on each of the next two anniversaries of the grant date, July 1, 2022, subject to the Reporting Person's continued compliance with the terms of the Restricted Stock award agreement.
• REMARKS: The Power of Attorney for Martin Lawson is filed as an exhibit to the Form 3 filed by Mr. Lawson with the Securities and Exchange Commission on June 24, 2025, which is hereby incorporated by reference.